Sabero Organics Peer Comparison

NSE: SABERORGAN | BSE: 524446

₹174.85

₹-2.00 (-1.13%)

As on 15-Jan-2015IST

Market cap

₹593 Cr

Revenue (TTM)

₹813 Cr

P/E Ratio

21.2

P/B Ratio

4.8

Div. Yield

0 %

Edit

	Sabero Organics	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Market cap (₹ Cr)	593	24,932	17,972	6,992	4,509
Revenue (₹ Cr)	813	3,245	5,595	5,357	1,953
Net Profit (₹ Cr)	27.93	579.39	732.10	626.21	268.04
Net Margin (%)	3.43	17.04	12.71	11.46	13.42
RoE (%)	24.53	17.35	24.05	21.55	16.62
Price to Earnings	21.22	43.03	24.55	11.17	16.82
Price-To-Book	4.77	6.92	5.47	2.17	2.74

Income Statement (₹ Cr)

	Sabero Organics	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Operating Revenue	813.47	651.44	3,245.20	790.37	738.41
Total Income	814.36	654.60	3,336.10	823.20	743.20
Total Expenditure	730.20	603.74	2,840.30	631.00	617.85
EBITDA	83.27	47.69	404.90	159.38	120.56
Depreciation	15.00	6.31	50.20	28.93	4.84
EBIT	68.26	41.39	354.70	130.45	115.72
Interest	27.24	1.59	4.80	7.91	4.17
Other Income	0.89	3.16	90.90	32.83	4.79
Exceptional Items	--	--	1,174.70	--	--
Profit before Tax	41.91	42.96	440.80	155.37	116.34
Provision for Tax	13.98	9.81	151.30	44.32	23.20
Profit after Tax	27.93	33.15	289.50	111.05	93.14

	Sabero Organics	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Shareholder's Funds	124.36	196.61	1,742.30	555.74	332.50
Minority Interest	0.00	--	--	0.02	--
Non-Current Liabilities	36.75	-3.23	52.50	10.40	18.98
Current Liabilities	542.34	242.89	1,667.00	348.02	165.82
Total Liabilities	584.29	440.07	3,475.70	914.18	517.30

	Sabero Organics	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Non-Current Assets	236.19	62.54	536.50	231.25	110.65
Current Assets	467.26	373.72	2,925.30	682.93	406.65
Total Assets	584.29	440.07	3,475.70	914.18	517.30
Total Debt*	321.93	0.00	0.00	39.93	39.41
Net Current Assets	-75.08	130.83	1,258.30	334.91	240.83
Contingent Liabilities	9.22	25.60	142.10	34.77	5.01

	Sabero Organics	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Cash From Operating Activities	8.04	19.54	281.50	156.29	33.36
Cash Flow from Investing Activities	-18.87	-7.93	-289.70	-150.85	-19.41
Cash from Financing Activities	11.00	-0.74	-479.60	-21.86	-17.03
Net Cash Inflow / Outflow	0.17	10.87	-487.80	-16.42	-3.09

	Sabero Organics	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
ROCE (%)	16.50	24.67	24.26	29.48	36.06
ROE (%)	24.53	18.42	15.76	21.74	31.29
ROA (%)	4.28	8.26	8.51	13.00	19.86
EBIT Margin (%)	8.39	7.81	15.28	24.32	16.97
Net Margin (%)	3.43	5.06	8.68	13.49	12.53
Cash Profit Margin (%)	0.00	5.69	9.99	17.71	11.82

	Sabero Organics	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Revenue Growth (%)	25.22	31.71	19.08	1.84	26.81
EBIT Growth (%)	13.80	145.92	15.63	24.65	41.08
Net Profit Growth (%)	-10.95	159.41	-75.08	32.33	44.51
EPS Growth (%)	-10.89	159.42	-73.11	32.27	44.51
Book Value Growth (%)	46.45	20.28	-9.79	19.27	26.54

	Sabero Organics	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Price / Earnings	12.99	0.00	19.05	0.00	13.60
Price / Book Value	4.06	0.00	3.17	0.00	3.81
Dividend Yield (%)	0.00	--	0.36	--	1.58
EV/EBITDA	9.46	4.01	10.15	0.56	10.40
Market Cap (₹ Cr)	419.75	0.00	5,516.17	0.00	1,266.99

	Sabero Organics	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Debt to Equity	0.21	0.00	0.00	0.07	0.12
Short term debt to equity ratio	2.17	0.01	--	0.07	0.12
Current Ratio	0.86	1.54	1.75	1.96	2.45
Quick Ratio	0.66	0.86	1.43	1.73	1.18
Interest Coverage	2.54	28.00	92.83	20.65	28.91

	Sabero Organics	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Debtors to sales (%)	36.59	23.93	12.63	50.64	23.07
Asset Turnover	1.25	1.73	1.00	0.93	1.77
Receivable days	83.97	75.32	39.32	179.35	70.67
Inventory Days	40.43	78.62	56.35	40.10	81.71
Payable days	56.37	127.88	42.92	142.38	43.73
Cash Conversion Cycle	68.04	26.06	52.74	77.08	108.65

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.